Skip to content

Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder

Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder: Study Protocol for a Randomised Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07207512
Acronym
EFT-PGD
Enrollment
128
Registered
2025-10-06
Start date
2026-04-06
Completion date
2029-09-01
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged Grief Disorder (PGD)

Keywords

grief, bereavement, prolonged grief disorder, grief with complications, Emotion-Focused Therapy, PGD, Randomized Controlled Trial, RCT, study protocol, Treatment Effectiveness

Brief summary

The goal of this clinical trial is to learn if Emotion-Focused Therapy (EFT) works to reduce symptoms of Prolonged Grief Disorder (PGD) in adults. PGD happens when the pain of losing a loved one lasts a long time and causes serious problems in daily life. * The main questions this study aims to answer are: 1. Does EFT lower grief symptoms in adults with PGD? 2. Does EFT also help with related problems, such as anxiety, depression, trauma, and overall distress? * Who can take part: Adults (18 years or older) who lost a loved one at least 6 months ago and meet the criteria for PGD. \- What will happen in the study: Participants will be randomly assigned to one of two groups: 1. EFT group: 8 to 10 weekly, face-to-face therapy sessions with a trained therapist. 2. Self-help group: 10 weekly self-help exercises based on EFT, completed on their own. * All participants will complete questionnaires on grief, mood, and well-being before starting, during the study, at the end of treatment (12 weeks), and again at 5 months and 12 months after starting. * In the EFT group, the therapeutic relationship will also be measured during sessions 3 and 8. * Why this study is important: Most current treatments for grief are based on cognitive-behavioral therapy, but not everyone benefits from them. EFT is a promising therapy that focuses on emotions and has shown positive results for other mental health problems. This trial will test if EFT can be an effective treatment for people struggling with prolonged grief.

Interventions

BEHAVIORALEmotion-Focused Therapy for Grief

The EFT intervention will follow the model described in EFT for grief. Its main goal is to transform core emotional pain (e.g., chronic shame) by activating change-inducing emotions (e.g., assertive anger), a process described as "changing emotion with emotion." This work takes place within a safe and supportive therapeutic relationship, characterized by the therapist's empathic, accepting, and compassionate stance. Therapists remain attuned to emotional markers (e.g., self-criticism, unfinished business) that signal opportunities for targeted work on specific affective problems, which are usually addressed through experiential tasks such as the Empty-Chair for Unfinished Business. Although EFT is transdiagnostic, grief work has certain distinctive features, such as the central role of experiencing grief-related sadness and fostering a sense of connection with the deceased.

BEHAVIORALSelf-help intervention based on EFT

The self-help intervention consists of 10 written exercises designed to address different aspects of grief. These include psychoeducation, emotional regulation, focusing on bodily awareness, softening self-criticism, reducing avoidance, managing anxiety and fear, clarifying confusing emotional reactions, processing trauma, imaginal dialogues with the deceased, and cultivating compassion.

Sponsors

Universidad Pontificia Comillas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (≥18 years). * Undergoing a grief process (including perinatal grief). * Meeting ICD-11 diagnostic criteria for Prolonged Grief Disorder, assessed with the Traumatic Grief Inventory - Clinician Administered (TGI-CA); death occurred six months or more prior to assessment; PG-13-R score ≥30. * Provision of informed consent. * Stable psychopharmacological medication for at least six weeks prior to therapy onset, with physician approval to maintain stability during the intervention.

Exclusion criteria

* Concurrent psychological treatment * Bereavement occurring less than six months prior to the loss * Substance abuse * Eating disorder * Psychosis; * Organic brain syndrome * Suicide risk * Risk of harm to others.

Design outcomes

Primary

MeasureTime frameDescription
Prolonged Grief Scale 13 - RevisedFrom enrollment to the end of the research at 1 year follow-upHigher scores indicate greater symptomatology of Prolonged Grief Disorder; a score of 30 or higher meets the clinical threshold for Prolonged Grief Disorder.

Secondary

MeasureTime frameDescription
Centrality of Event ScaleFrom enrollment to the end of the reserch at 1 year follow-upHigher scores indicate greater trauma symptomatology
Clinical Outcomes in Routine Evaluation-10From enrollment to the end of the reserch at 1 year follow-upHigher scores indicate greater psychological distress
Patients Health Questionnarie 9From enrollment to the end of the reserch at 1 year follow-upHigher scores indicate greater psychological distress
Generalized Anxiety Disorder-7 ScaleFrom enrollment to the end of the reserch at 1 year follow-upHigher scores indicate greater GAD symptomatology
TGI-CAPost-treatment (12 weeks), 5-month and 12-month follow-upProportion of participants no longer meeting ICD-11 diagnostic criteria for prolonged grief disorder, assessed with the Traumatic Grief Inventory - Clinician Administered (TGI-CA).

Countries

Spain

Contacts

CONTACTJosé Gamoneda, PhD
jgamoneda@comillas.edu+34636894995
CONTACTRafael Jódar, PhD
rafajodar@comillas.edu91 734 39 50
PRINCIPAL_INVESTIGATORJosé Gamoneda, PhD

Universidad Pontificia Comillas

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026